A subset of human acute lymphoblastic leukemias are driven by mutations of the interleukin-7 receptor (IL7R) and cytokine receptor-like factor 2 (CRLF2), causing aberrant signaling due to disulfide-mediated receptor activation.…
Read More
Congratulations to Paolo for being selected as American-Italian Cancer Foundation Fellow! For more than 30 years, AICF has supported both improved patient care and innovative cancer research, and we are grateful for…
Read MoreMechanisms of cancer drug susceptibility and resistance, lecture for the SKI/Cornell Pharmacology Graduate Program, May 2014: pdf
Read MoreEdwin M. Stone (edwin-stone[at]uiowa.edu) Reproduced with permission The basics your mother taught you: work hard, obey the golden rule, put some data in your book every day, read the literature,…
Read More(Bio)chemical proteomics, lecture for the SKI/Cornell Pharmacology Graduate Program, October 2013: pdf
Read MoreReview Commons is now LIVE. @PLOS We are excited to be part of this experiment in journal-independent peer review led by @ASAPbio_ and @embojournal with 17 journals in total. https://t.co/1xx7p2GGyN
What a thread! what great comments! Awesome awesomeness thanks! https://t.co/wxYRRUH99U
That's equivalent to more than one million biomedical NIH research grants, or enough to fund the current national program for more than 200 years! What Did the U.S. Get for $2 Trillion in Afghanistan? https://t.co/gkGF6jBprf
Could evolution of cellular nuclei be promoted by inter-organismal conflict? Escape from CRISPR interference by phages in bacteria suggests that this may be so: https://t.co/putckkIRw6
Important work @Armstrong_dfci and colleagues on the new Menin-MLL Inhibitor for AML. Clinical trial is highly promising and imminent. https://t.co/vtuyS07TXd
